Andrew Baum Stock Analyst Profile - Citigroup Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Andrew Baum

    Stock Analyst at Citigroup

    (4.55)
    # 1470
    Out of 5,506 analysts
    51
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Drug Manufacturers - General Drug Manufacturers - Specialty & Generic Biotechnology

    8 Stocks

    Name Action PT Current % Upside Ratings Updated
    PFE Pfizer
    Maintains: Neutral
    25 26
    		27.36 -4.97% 7 Aug 6, 2025
    BMY Bristol-Myers Squibb
    Maintains: Neutral
    51 47
    		45.44 3.43% 10 Aug 1, 2025
    MRK Merck & Co
    Downgrades: Neutral
    115 84
    		89.17 -5.8% 10 May 14, 2025
    RPRX Royalty Pharma
    Maintains: Buy
    60 40
    		36.07 10.9% 2 Oct 25, 2024
    ABBV AbbVie
    Maintains: Strong Buy
    170 215
    		233.87 -8.07% 11 Oct 25, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Strong Buy
    675 895
    		840.01 6.55% 7 Apr 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Neutral
    5 10
    		8.32 20.19% 3 Oct 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 1 Jul 5, 2017